We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microfluidic Cassette Analyses Genes and Proteins

By LabMedica International staff writers
Posted on 14 Sep 2010
A device that quickly identifies genes and proteins in body fluids has been developed that could make a vital difference to the trauma patients doctors treat. More...


A new method to isolate cells from patient samples is under development and analyzing them will help predict outcomes after severe trauma The technology, called a microfluidic cassette, allows precise analysis of very small volumes of fluids and can be used to study patients' genes and proteins.

Knowing the genomic signature of a cell population can help doctors diagnose diseases and may allow them to predict how individual patients will respond to trauma and what treatments to order. The approach also could be used with patients who have cancer or other conditions. Scientists at the University of Florida, (UF; Gainesville, FL, USA), developed and tested the cassette to isolate neutrophils, the first type of white blood cell on the scene of an infection, and to analyze the proteins they produce. A sample of fluid, such as blood or urine, is pumped through the device, which is laced with antibodies that capture the individual cells.

Testing showed the device yielded pure samples of neutrophils, and their gene expression pattern was consistent with results from tests performed in previous studies. The team was able to identify 63 genes that are differentially expressed. The genes in question regulate functions of the immune system. Patients, whose expression of these genes is abnormal, are less likely to return to their normal immune function within days of trauma, as most patients do. This leaves them more vulnerable to infections and a myriad of related complications.

Lyle L. Moldawer, Ph.D., a professor at UF said, "What is so powerful about this technique is that you can isolate any cell population quickly and efficiently at the bedside. In this case we isolated blood neutrophils, but we' have also isolated T cells, mixed leukocytes, monocytes. Theoretically, you can isolate any cell population, under any disease, and rapidly get nucleic acids to produce a genomic signature."

Kenneth Kotz, Ph.D., a research fellow at Massachusetts General Hospital (Boston, MA, USA) added, "We are getting 100 ng of ribonucleic acid (RNA) from 0.15 mL of blood and we're doing it all in 30 minutes. No one has really ever been able to do this for neutrophils. No one has been able to demonstrate the speed and the sample quality with these small blood volumes." The results of the study were published September 2010 in Nature Medicine.

Related Links:
University of Florida
Massachusetts General Hospital



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Urine Analyzer
respons® UDS100
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.